Delivery Order SPE2DR25D2007-SPE2DR26FM39C
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at approximately $20.9K to AmerSourceBergen Drug Corp for the supply of Benlysta 200 mg/mL auto-injector on January 12, 2026. The contract is firm fixed-price with a completion date of February 3, 2026, and carries no set-aside designation, indicating it was competitively awarded. The awardee, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order operates as a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $6,966.08 firm fixed-price delivery order on January 13, 2026, for Benlysta 200 mg/ml syringes, with an ultimate completion date of February 4, 2026. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and...
- The Defense Logistics Agency (DLA) awarded a $3,486.67 firm fixed-price delivery order to AmerSourceBergen Drug Corp on January 12, 2026, for Benlysta 200 mg/mL auto-injector medication. The award, which is not set aside for any specific business category, is scheduled for completion by February 3, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerSourceBergen Drug Corp's parent company Cencora, Inc.'s larger...
- The Defense Logistics Agency awarded a $13,678.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Benlysta 400 mg vials, with an ultimate completion date of October 2, 2025. This non-set-aside contract represents a competitive award to the pharmaceutical distributor for this specialized medication. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and maintains extensive...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of Benlysta 200 mg/mL syringes. The $2,790.98 delivery order has a completion date of March 14, 2024. AmerisourceBergen Drug Corp serves as the prime contractor on this order, which is not designated as a set-aside contract. AmerisourceBergen Drug Corp also holds an indefinite delivery contract...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 400 mg vials of the drug BENLYSTA. The $6,297.50 order has a completion date of February 6, 2024 and was awarded on January 16, 2024. Amerisourcebergen Drug Corp is a prime contractor that has received numerous awards from DLA Troop Support Medical to supply pharmaceuticals and medical supplies to support military treatment...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide BENLYSTA 400 MG vials. The $1,259.50 order is part of a larger contract with DLA Troop Support Medical to supply pharmaceuticals, medical supplies, and distribution services. AmerisourceBergen, a leading global pharmaceutical distributor, has previously received multiple contract awards from DLA to deliver a range of medical...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, for the supply of 120 mg vials of the drug Benlysta. The $1,137.60 contract has a completion date of February 20, 2024 and is not associated with any set-aside designation. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is a subsidiary of the larger Amerisourcebergen...
- The Defense Logistics Agency awarded a delivery order valued at $3,242.05 to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Benlysta 200 mg/mL syringes. This non-set-aside, competitively awarded contract represents a firm fixed price delivery order with an ultimate completion date of January 6, 2026. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary distribution...
- The Defense Logistics Agency awarded a delivery order valued at $6,497.32 to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injectors, with an ultimate completion date of January 22, 2026. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran...
- SPE2DR25D2007Indefinite Delivery Contract
- SPE2DR25D2007-SPE2DR26FM39CDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $17,472.12 to AmerSourceBergen Drug Corp for the supply of Benlysta 400 mg vials, with an ultimate completion date of February 4, 2026. This is a firm fixed-price contract with no set-aside designation, issued competitively to the prime contractor. The work will be performed at AmerSourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerSourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026, which enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerSourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerSourceBergen), is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement. The company demonstrates extensive experience fulfilling federal medical supply needs through its portfolio of delivery orders covering diverse therapeutic domains including specialty medications, brand-name and generic drugs, vaccines, and medical devices. The DLA Troop Support Medical relationship reflects the company's capability to serve Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible and comprehensive contract vehicles supporting military treatment facilities and veterans' healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.5k | 1/12/26 |